Cleveland-Cliffs Inc. is rated a Sell with $9.33/share target with challenges in US manufacturing & margin pressures. Read ...

Cleveland-Cliffs has struck a "transformative" agreement with South Korea's largest steel producer. Here's why the deal makes ...

Cleveland-Cliffs intends to issue 75 million shares to pay down debt, triggering a selloff by shareholders on fears the ...

Cliffs Inc. (NYSE: CLF) is pleased to announce that POSCO, Korea’s largest steelmaker and the world’s third largest ...

The tentative collaboration between two steel giants promises to bring significant foreign investment to American shores, ...

Cleveland-Cliffs Inc. is seeking to raise as much as $982.5 million in a share sale, as the steel and iron-ore pellet ...

Curious whether Cleveland-Cliffs is a bargain or a value trap? You’re not alone, especially with so much buzz around the stock’s current price. This year so far, shares have climbed 24.4%, but were ...

Cleveland-Cliffs announced that POSCO, Korea’s largest steelmaker and the world’s third largest steelmaker outside of China, ...

Cleveland-Cliffs Inc. (NYSE: CLF) announced Thursday, Oct. 30, that is has entered into a partnership with South Korean ...

Jim Lebenthal, Chief Equity Strategist at Cerity Partners, explained in a recent program on CNBC why he’s buying more ...

Cleveland-Cliffs Inc. announced October 30 that it had entered into a strategic partnership with POSCO, the largest steelmaker in South Korea. According to a joint release, POSCO will make “a ...

Cleveland-Cliffs shares gained 1.4% to close at $12.43 on Friday while Bristol-Myers Squibb shares gained 1% to close at $46.07.